Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Essex Bio-Technology Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Essex Bio-Technology Ltd (1061-HK)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 May 2016 Thomson Reuters Stock Report 11 $25.00

Essex Bio-Technology Limited (1061) - Financial Analysis Review

Essex Bio-Technology Limited (1061) - Financial Analysis Review Summary Essex Bio-Technology Limited (Essex) is a biopharmace...

16 May 2016 GlobalData 28 $300.00

Wright Investors Service Comprehensive Report for Essex Bio-Technology Limited

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

04 May 2016 Wright Reports 56 $75.00

Thomson Reuters Stock Report - Essex Bio-Technology Ltd (1061-HK)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

03 May 2016 Thomson Reuters Stock Report 11 $25.00

Essex Bio-Technology Limited (1061) - Financial Analysis Review

Essex Bio-Technology Limited (1061) - Financial Analysis Review Summary Essex Bio-Technology Limited (Essex) is a bioph...

21 Mar 2016 GlobalData 21 $125.00

Essex Bio-technology (1061.HK): Emerging Player in Ophthalmology and Surgery

Essex Bio-technology 1061 HK Emerging Player in Ophthalmology and Surgery Early mover in rb-bFGF research. Essex Bio-tec...

15 Mar 2016 SBI China Capital 13 $138.00

Essex Bio-Technology Limited: Upgraded to Good

14 Mar 2016 Sadif Analytics Prime 3 $10.00

Should Investors Steer Clear of the Essex Bio-Technology Limited?

14 Mar 2016 Sadif Analytics Prime 12 $25.00

亿胜生物科技(1061. HK)——内生+外延推动高速增长

最新关注:亿胜生物科技是一家以基因重组技术,尤其是重组碱性成纤维细胞生长因子(bFGF)为研发重心和产业化的生物科技公司,总部位于珠海。集团产品主要涵盖眼科和 外科。2015 年上半年收入HKD3.13 亿,同比增长35.5%,毛利HKD2.57 ...

25 Jan 2016 SBI China Capital 5 $35.00